TMS for Insomnia: Restoring Healthy Sleep Through Brain Stimulation

Everything you need to know about TMS for Insomnia: Restoring Healthy Sleep Through Brain Stimulation — how it works, what it costs, and how to find a provider who actually knows what they're doing.

Insomnia is one of the most common health complaints in the modern world, with insomnia symptoms affecting a large share of adults and chronic insomnia disorder affecting roughly 10%. Chronic insomnia — defined as difficulty sleeping at least three nights per week for three months or longer — is associated with a host of negative outcomes including increased risk of depression, anxiety, cardiovascular disease, diabetes, and impaired cognitive performance. While cognitive-behavioral therapy for insomnia (CBT-I) remains the gold-standard treatment, it is not effective for all patients. Transcranial magnetic stimulation (TMS) is being studied as a neuromodulation approach for insomnia. It is investigational for this use and not FDA-cleared for insomnia.

Related: TMS and Sleep · TMS for ADHD · TMS for Multiple Sclerosis Fatigue

What You’ll Learn

• How sleep-wake circuits in the brain interact and regulate each other
• Why the medial prefrontal cortex hyperarousal is central to insomnia
• The innovative approach of night-time TMS sessions and their benefits
• What research shows about TMS for improving sleep quality and architecture
• How to combine TMS with CBT-I for the best outcomes

The Neuroscience of Sleep and Wakefulness

Healthy sleep depends on a delicate interplay between brain structures that promote sleep and those that maintain wakefulness. Understanding this balance is key to understanding how TMS can help.

The ascending reticular activating system (ARAS) is a network of neurons in the brainstem and hypothalamus that projects throughout the cortex, maintaining arousal and wakefulness. Neurotransmitters involved in this system include serotonin, norepinephrine, acetylcholine, histamine, and orexin. When the ARAS is active, it suppresses sleep-promoting regions and keeps the cortex alert.

The sleep-promoting system is anchored in the ventrolateral preoptic area (VLPO) of the hypothalamus. When the VLPO is active, it inhibits the arousal centers, allowing the cortex to transition into sleep. This mutual inhibition between sleep-on and wake-on systems creates a flip-flop switch that governs the sleep-wake transition.

In chronic insomnia, neuroimaging studies reveal that the prefrontal cortex — particularly the medial prefrontal cortex (mPFC) — often shows heightened activity during the transition to sleep and during sleep itself. This hyperarousal of the prefrontal cortex is thought to be a key mechanism of insomnia: the brain’s executive center fails to “power down,” preventing the transition to restorative sleep.

Additionally, the default mode network (DMN), a set of brain regions active during rest and mind-wandering, is often abnormally active in insomnia patients. The DMN includes the mPFC, posterior cingulate cortex, and angular gyrus — regions that are highly active when people lie in bed at night, replaying worries and ruminating.

See also: TMS for ADHD in Adults · I'd Given Up on Feeling Better — Then I Tried TMS

How TMS Targets Insomnia

TMS for insomnia typically targets the medial prefrontal cortex (mPFC) and, to a lesser extent, the dorsolateral prefrontal cortex (dlPFC). The goal is to reduce the hyperarousal in prefrontal and DMN regions that prevents natural sleep onset and maintenance.

Low-frequency (inhibitory) TMS applied to the mPFC has been proposed to reduce activity in this region and improve sleep quality. The rationale is that calming prefrontal hyperarousal may help restore normal sleep, but this is not established.

High-frequency (excitatory) TMS to specific targets has also been explored, with the goal of enhancing the activity of sleep-promoting circuits. Some researchers have targeted the thalamus — the brain’s sensory relay and sleep-wake switch — in early research.

Night TMS Sessions: A Unique Approach

One experimental idea in TMS for insomnia is the use of night-time TMS sessions, in which stimulation is delivered while the patient is in bed, shortly before or during the natural sleep onset period.

The theory is that stimulating around the transition to sleep might affect sleep-regulating circuits differently than daytime stimulation. This is a hypothesis; night-time TMS is experimental, and there is no established protocol or proven advantage over daytime sessions.

See also: TMS for Fibromyalgia: Targeting Chronic Pain at Its Source · FDA Clearance History for TMS Devices: A Complete Timeline

Research Evidence

Studies so far are small and use varied protocols. A 2021 meta-analysis of randomized sham-controlled trials (Ma et al., Frontiers in Psychiatry) reported better Pittsburgh Sleep Quality Index scores with rTMS than with sham, while another meta-analysis judged the overall effect uncertain because of differences between studies and weak blinding. Durability of any benefit is not well established. Larger, well-controlled trials are needed.

Integrating TMS With Sleep Hygiene and CBT-I

TMS is not intended to replace established insomnia treatments but rather to complement them. Cognitive-behavioral therapy for insomnia (CBT-I) remains the first-line treatment, and TMS is most effectively used in combination with CBT-I for patients who do not achieve adequate relief from therapy alone.

There is no established TMS protocol for insomnia. In general, CBT-I comes first, and TMS would only be considered, ideally in a research or specialist setting, for people with persistent insomnia who have not responded to it.

See also: Neurofeedback Therapy · TMS vs Antidepressants: Brain Stimulation vs Medication

Practical Considerations

Protocols in research studies vary, but typically involve daily sessions over one to several weeks, each lasting around 20 to 30 minutes.

Side effects are generally mild and include transient headache, scalp discomfort, and occasional drowsiness after treatment. Importantly, TMS does not carry the risk of dependence or next-day sedation that is associated with many sleep medications.

[For chronic insomnia patients](/specialists/) who have tried multiple medications and therapy approaches without adequate relief, TMS is an investigational option that targets the brain’s sleep-regulating circuits, though it is not yet an established treatment.